AMHERST, N.Y., Feb. 29, 2016 -- Allied Motion Technologies Inc. (NASDAQ:AMOT) (“Company”), a global designer and manufacturer of motion control products, announced today that it will release its fourth quarter and full year 2015 results after the close of financial markets on Wednesday, March 9, 2016. The Company will host a conference call and webcast to review the financial and operating results for the period. A question-and-answer session will follow.
| Fourth Quarter and Full Year 2015 Conference Call | ||
| Date: | Thursday, March 10, 2016 | |
| Time: | 11:00 a.m. Eastern Time | |
| Live Call: | Pre-register via the link below to receive a return email containing the dial-in number and a unique PIN to gain immediate access to the call. | |
| Pre-registration link: | ||
| http://services.choruscall.ca/DiamondPassRegistration/register?confirmationNumber=1000425&linkSecurityString=1ab6d7c0 | ||
| Webcast: | www.alliedmotion.com/InvestorRelations | |
A telephonic replay will be available from 2:00 p.m. ET on the day of the call through Thursday,
March 17, 2016. To listen to the archived call, dial (858) 384-5517 and enter replay pin number 1000425
or access the webcast replay via the Company’s website at www.alliedmotion.com/InvestorRelations.
About Allied Motion Technologies
Allied Motion (NASDAQ:AMOT), designs, manufactures and sells precision and specialty motion control components and systems used in a broad range of industries within our major served markets, which include the Vehicle, Medical, Electronics, Industrial, and Aerospace and Defense. The Company is headquartered in Amherst, NY, has global operations and sells into markets across the United States, Canada, South America, Europe and Asia.
Allied Motion is focused exclusively on motion control applications and is known worldwide for its expertise in electro-magnetic, mechanical and electronic motion technology. Its products include brush and brushless DC motors, brushless servo and torque motors, coreless DC motors, integrated brushless motor-drives, gear motors, gearing, modular digital servo drives, motion controllers, incremental and absolute optical encoders, and other associated motion control-related products. The Company’s growth strategy is focused on becoming the motion solution leader in its selected target markets by leveraging its “technology/know how” to develop integrated solutions that utilize multiple Allied Motion technologies to “change the game” and create increased value solutions for its customers.
The Company routinely posts news and other important information on its website at http://alliedmotion.com.
For more information, contact:
| Company Contact: | Investor Contact: |
| Sue Chiarmonte Allied Motion Technologies Inc. Phone: 716-242-8634 x602 Email: [email protected] | Deborah K. Pawlowski Kei Advisors LLC Phone: 716-843-3908 Email: [email protected] |


Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Instagram Outage Disrupts Thousands of U.S. Users
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Washington Post Publisher Will Lewis Steps Down After Layoffs
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 



